SUMMARY
Introduction
Worldwide, we are witnessing a strong promotion on the reduction in use of synthetic products1. The emergence of resistance to broad-spectrum antibiotics, the appearance of hypersensitivity to the drugs, toxicity as a result of improper and excessive application, represent just some of the consequences of the use of synthetic antimicrobial agents.
Recently, many scientists began to understand the importance of traditional medicine; data regarding application of medicinal plants can be searched in historical manuscripts but have to be verified by a modern science in order to develop an effective drug 2 . Taking into account that plants produce hundreds or even thousands of metabolites, it is obvious that there is a great interest in their chemical evaluation 3 . In recent decades, scientists have carried out an intensive biological and chemical examination of the plant secondary metabolites 4, 5 , particularly essential oils. In oral medicine, essential oils are used in many different ways, such as: in oral hygiene, in dental implants, as anxiolytic and preservatives 6 .
Oral cavity has over 700 different types of microorganisms of which, currently, more than a half is not possible to cultivate in the laboratory conditions. Around 400 species derive from periodontal pockets, while about 300 species are isolated from the mucous membrane, carious lesions, tongue and other human oral cavity surfaces 7 . The most common oral infection, with a growing trend in the last decades, is candidiasis, whose main causative agent is opportunistic pathogen Candida albicans. Although it is a part of normal Melaleuca alternifolia (organic) from Bergland-Pharma GmbH and Co. KG.
Essential oil analysis
Procedure used for GC-FID and GC-MS analyses complies with standards set for Gas Chromatography of essential oils.
GC-FID analysis was performed on GC Agilent Technologies 7890A apparatus, equipped with the splitsplitless injector and automatic liquid sampler (ALS), attached to HP-5 column (30 m x 0.32 mm, film thickness 0.25 µm) and fitted to flame-ionization detector (FID). Operating conditions were as follows: carrier gas was H2 (1 ml/min/210°C); temperatures of injector and detector were set at 250°C and 280°C, respectively, while the column temperature was linearly programmed 40-260°C at 4°C/min. Solutions of essential oils' samples in ethanol (ca. 1%) were consecutively injected by ALS (1 µl, splitmode). The percentile presence of components in essential oils' samples were calculated from the peak areas obtained in the area-percent reports (obtained as a result of standard processing of chromatograms) without correction factors, using normalization method.
The GC/MS was performed on HP G 1800C Series II GCD analytical system equipped with HP-5MS column (30 m×0.25 mm, film thickness 0.25 µm). Carrier gas was He (1 ml/min). Other chromatographic conditions were as those for GC-FID. Transfer line was heated at 260°C. Mass spectra were recorded in EI mode (70 eV), in a range of m/z 40-450. Solutions of essential oil samples in ethanol (ca. 1%) were consecutively injected by ALS (0.2 µl, split mode).
The identification of essential oils components was based on matching of their mass spectra peaks with those from Wiley275 and NIST/NBS libraries. The experimental values for Kovats' retention indices (RI) were determined by using calibrated Automated Mass Spectral Deconvolution and Identification System software AMDIS (ver. 2.1.), compared to those from available literature 15 , and they were used as additional tool to support MS findings.
Microorganisms
The following seven clinical oral isolates: Streptococcus pyogenes (IBR S004), Streptococcus mutans (IBR S001), Lactobacillus acidophilus (IBR L001), Streptococcus salivarius (IBR S006), Streptococcus sangunis (IBR S002), Streptococcus sanguis (IBR S005), Enterecoccus feacalis (IBR E001), Pseudomonas aeruginosa (IBR P001) and one reference strain, Staphylococcus aureus (ATCC 25923), were used in the study. In antifungal assay, fifty eight clinical isolates of Candida spp., as well as two references strains (Candida albicans ATCC 10231 and Candida tropicalis ATCC 750), were used. The reference strains were obtained from the collection of the Laboratory microbiota, after the homeostatic conditions in oral cavity changes, it starts overgrowing and causing very specific symptoms 8 . The most common reasons for the infection use to be the excessive use of broad-spectrum antibiotics, immunosuppressant's (corticosteroids and cytostatics), inadequate dentures an poor oral hygiene 9 . During the mid-twentieth and early twenty-first century, a rise in the number of species of the genus Candida infections, especially in immunocompromised patients (HIV, diabetes, cancer) was recorded 10 . This provoked a great interest in studying existing therapeutic procedures and causes of infections that may range from mucosal lesions to the life-threatening systemic infections.
In addition to Candida spp., species of the genera Staphylococcus, Enterobacter and Pseudomonas are also a common cause of pathogenic conditions in the human oral cavity 11 . While the C. albicans was detected in 55.5%, 61.1% and 61.1% samples from the maxillary defect area, prosthesis and saliva, respectively, S. aureus was detected in 44.4% of the nasal cavity samples, and all samples of saliva from the same patients were positive for this pathogen, except one. None of the patients were suffering from any subjective complains, while 50% of them had diffuse erythema in the defect area. Both C. albicans and S. aureus were detected together in 22.2% of all saliva samples 12 . Patients with symptoms of denture related stomatitis (DRS) and poor denture hygiene had in their saliva a pronounced number of C. albicans 13 .
Caries is a chronic disease of the tooth hard tissues, leading to demineralization and decay. Some studies indicate the important role of some Streptococcus bacteria strains in etiology of this disease 14 , among which the most common belong to Streptococcus mutans group, and the other ones were species S. sobrinus, S. salivarius, S. mitis, S. constellatus, S. parasanguinis, Lactobacillus spp. and Vellionella spp. Actinomyces species are involved in the initial stages of caries, while the S. mutans in the later ones 7 .
The enormous structural diversity of natural compounds of plant origin provides opportunity to obtain effective antimicrobial agents. Since biological activities of essential oils have been extensively studied, and some of them were scientifically confirmed, they represent an ideal model for study and use in prevention and treatment of the human oral diseases caused by the most common pathogens.
Material and methods

Essential oils
Three EOs were used in this study, all of them were purchased as commercial samples; Citrus limon L. oil from "Scents & Sensibility ltd.", USA, Piper nigrum L. oil from "Athens Herbal Pharmacy", Greece, and
In the oil of R. officinalis, 1.8-cineol was the major constituent (43.8%), followed by trans-pinocamphone (12.5%), α-pinene (11.5%), and β-pinene (8.2%). The most abundant constituents of S. officinalis EO were cisthujone (32.7%), camphor (17.2%), 1.8-cineol (10.1%), α-pinene (8.6%), trans-thujone (7.7%), and camphene (7.3%). The chemical profile of our commercial EO sample of H. officinalis is in agreement with previous studies 21, 22 , though there is another study of the oil of H. officinalis revealing β-pinene and camphor being the major oil components, in addition to pinocamphone 23 .
Antimicrobial activity
In general, all EOs exhibited significant antimicrobial activity against tested microorganisms ( Table 2 and Table 3) ; inhibition values ranged for MIC 0.16-1.25 mg/ml and MBC 0.63-2.50 mg/ml for bacteria, and MIC 0.13-63 mg/ml and MFC 0.50-1.25 mg/ml for Candida spp.
The strongest activity against bacteria was achieved by H. officinalis and R. officinalis oils (MIC 0.16-0.63 mg/ml and MBC 0.31-1.25 mg/ml), while S. officinalis EO showed weaker antibacterial potential (MIC 0.63-1.25 mg/ml and MBC 1.25-2.50 mg/ml). The positive control used in this study, streptomycin, inhibited the growth of selected bacteria in the range MIC 0.01-0.15 mg/ml and MBC 0.01-0.20 mg/ml. Even Streptomycin showed better results in comparison to EOs, this result should be taken with caution; direct comparison of Streptomycin with EOs is better to avoid, since Streptomycin is commercial antibiotic and EOs are mixtures of natural compounds. On the other hand, commercial preparation Curasept (MIC 0.50-10.00, MBC 1.00-20.00 mg/ml) showed lower antibacterial potential compared to our EOs, with exception of S. sanguinis, while antibacterial potential of Hexoral (MIC 0.19-1.56, MBC 0.39-3.12 mg/ml) was lower in comparison to H. officinalis and R. officinalis oils, though it was similar to even better compared to S. officinalis EO ( Table 2) .
The results of antifungal activity of commercial H. officinalis EO (MIC 0.13-0.50, MFC 0.25-1.00 mg/ml) and R. officinalis EO (MIC 0.25-0.50, MFC 0.50-1.00 mg/ ml) showed the strongest biocidal effect with the lowest MIC and MFC values, while the oil from S. officinalis again showed lowest potential among the tested oils (MIC 0.31-0.63, MFC 0.63-1.25 mg/ml). In comparison to Fluconazole (MIC 0.0005-0.002; MFC 0.001-0.004 mg/ml) the EOs in our study generally showed lower activity (Table  3) . Positive control Curasept showed the lowest antifungal potential with MIC range from 5.00 to 10.00 mg/ml and MFC from 10.00 to 20.00 mg/ml, while Hexoral, as well, had weaker influence on tested fungi compared to EOs (MIC 1.00-1.25, MFC 2.00-2.50 mg/ml).
Recent study showed moderate antibacterial effect of H. officinalis essential oil 24 . Similar results were 
Minimum inhibitory (MIC) and minimum bactericidal/fungicidal (MBC/MFC) concentrations were determined by microdilution method in 96 well microtitre plates 18, 19 with some modifications. Briefly, fresh overnight cultures of bacteria were adjusted with sterile saline to a concentration of 1.0 x 10 5 CFU/well for bacteria and fungi, respectively. EOs were added in TSB medium for bacteria, SDB medium for C. albicans. The microplates were incubated for 24 h at 37° C for bacteria and 48 h at 37° C for yeasts. The MIC was defined as the lowest concentration of EO inhibiting the visible growth of the test strain. The MIC/MBC values for bacteria and yeasts were detected following the addition of 40 μL of p-iodonitrotetrazolium violet (INT) 0.2 µg/ml (Sigma I8377) and incubation at 37 °C for 30 min 20 . The MBCs/MFCs were determined by serial sub-cultivation of 10 µL into microtiter plates containing 100 µL of broth per well and further incubation for 24 h at 37° C. The lowest concentration with no visible growth was defined as the MFC, indicating 99.5 % killing of the original inoculum. Positive controls, antibiotics (Hexoral®, Streptomycin) and mycotic (Fluconazole), were used in both experiments.
Results and Discussion
Chemical composition of essential oils
Results of chemical analysis of essential oils (EO) used in this experiment is presented in Table 1 . It resulted in identification of 52 components representing 99.9-100.00% of the oils.
Oxygenated monoterpenes are the major portion of our EO samples, with the highest content observed in S officinalis (72.0%), somewhat lower in H. officinalis oil (65.9%) and the lowest in R. officinalis oil (63.9%). Twenty five compounds were identified in H. officinalis oil, accounting for 99.9% of the total EO; the major constituent was cis-pinocamphone (34.4%), followed by trans-pinocamphone (23.3%), and β-pinene (11.3%). in other study 26 Several articles report bactericidal effect of essential oil of R. officinalis 27, 28 . The oil is presented as very active in inhibiting the growth of S. aureus, E. coli, S. typhimurium and L. monocytogenes due to its abundance in monoterpenes (1,8-cineol, α-and β-pinene, camphor), which contribute to the EO's overall antibacterial activity 29 . Earlier studies on antifungal activity of this oil reported different results in comparison to ours; one study 30 showed moderate activity of oil to C. albicans and C. krusei (inhibiting their growth in concentrations of 0.5 and 1 mg/ml, respectively), while in other investigations 28 the oils from the same species originating from different localities in Turkey, also showed moderate to weak activity on C. albicans.
According to data from the literature 31-33 , antibacterial potential of S. officinalis EO, tested in vitro study, is very low; the lipophilic nature of some constituents of the essential oils from Salvia species resulted in a weak in vitro antibacterial activity as opposed to in vivo tests which showed very good activity 32 . In one study scientist compared the ability of C. albicans to adhere to two permanent soft liners and examined the effectiveness of alkaline peroxide-type denture cleansers in disinfection of contaminated long-term soft lining materials 34 . Since the mentioned cleaners could be toxic and destructive, here we could suggest the testing of natural products as an alternative.
Conclusion
In conclusion, present study shows that H. officinalis, R. officinalis, and S. officinalis essential oils possess broad-spectrum antimicrobial activity toward the oral microorganisms involved in various oral infections and diseases. The results of this study encourage the use of tested EOs in development of a novel agent that can be used in prevention and therapeutic treatments of human oral diseases. However, further in-depth study regarding the efficacy and safety should be conducted, followed by a number of clinical trials before the final product find its place at pharmacy shelves.
